134 related articles for article (PubMed ID: 33935532)
41. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
Lu W; Zeng X; Li N; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
[TBL] [Abstract][Full Text] [Related]
42. [Analysis of risk factor of perioperative complications in patients with radical gastrectomy for gastric cancer and its influence on prognosis].
Jin J; Deng J; Liang H; Sun C; Guo X; Guo J; Bai H; Liu H; Zhang N
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):53-60. PubMed ID: 29354900
[TBL] [Abstract][Full Text] [Related]
43. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer.
Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Terashima M
Ann Surg Oncol; 2013 May; 20(5):1575-83. PubMed ID: 23076557
[TBL] [Abstract][Full Text] [Related]
44. [Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment].
Wang TB; Mao QK; Zhang XJ; Zhou H; Guo CG; Chen YT; Zhao DB
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):160-166. PubMed ID: 33508922
[No Abstract] [Full Text] [Related]
45. Significance of lymphadenectomy with splenectomy in radical surgery for advanced (pT3/pT4) remnant gastric cancer.
Sugita H; Oda E; Hirota M; Ishikawa S; Tomiyasu S; Tanaka H; Arita T; Yagi Y; Baba H
Surgery; 2016 Apr; 159(4):1082-9. PubMed ID: 26497772
[TBL] [Abstract][Full Text] [Related]
46. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer.
Yu W; Choi GS; Chung HY
Br J Surg; 2006 May; 93(5):559-63. PubMed ID: 16607678
[TBL] [Abstract][Full Text] [Related]
47. Extended local resection for advanced gastric cancer: increased survival versus increased morbidity.
Martin RC; Jaques DP; Brennan MF; Karpeh M
Ann Surg; 2002 Aug; 236(2):159-65. PubMed ID: 12170020
[TBL] [Abstract][Full Text] [Related]
48. Impact of the anatomical location and the number of metastatic lymph nodes on gastric cancer patient´s survival.
Duchon R; Bernadic M; Pindak D
Bratisl Lek Listy; 2020; 121(4):253-258. PubMed ID: 32356438
[TBL] [Abstract][Full Text] [Related]
49. Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival.
Wanebo HJ; Kennedy BJ; Winchester DP; Stewart AK; Fremgen AM
J Am Coll Surg; 1997 Aug; 185(2):177-84. PubMed ID: 9249086
[TBL] [Abstract][Full Text] [Related]
50. Prognostic impact of infectious complications after curative gastric cancer surgery.
Han WH; Oh YJ; Eom BW; Yoon HM; Kim YW; Ryu KW
Eur J Surg Oncol; 2020 Jul; 46(7):1233-1238. PubMed ID: 32362466
[TBL] [Abstract][Full Text] [Related]
51. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
Bilici A; Selcukbiricik F
Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
[TBL] [Abstract][Full Text] [Related]
52. Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer.
Kanda M; Kobayashi D; Tanaka C; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Murotani K; Fujiwara M; Kodera Y
Gastric Cancer; 2016 Jan; 19(1):255-63. PubMed ID: 25563579
[TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection.
Bilici A; Seker M; Ustaalioglu BB; Kefeli U; Yildirim E; Yavuzer D; Aydin FM; Salepci T; Oncel M; Gumus M
Ann Surg Oncol; 2010 Aug; 17(8):2037-44. PubMed ID: 20333555
[TBL] [Abstract][Full Text] [Related]
54. Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer.
Lee KY; Noh SH; Hyung WJ; Lee JH; Lah KH; Choi SH; Min JS
Ann Surg Oncol; 2001 Jun; 8(5):402-6. PubMed ID: 11407513
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathologic characteristics and prognosis of gastric cancer patients underwent gastrectomy combined with splenectomy.
Wang F; Kang Y; Zu HL; Jiang H; Zhu L; Dong PD; Xue YW
Hepatogastroenterology; 2014; 61(136):2434-7. PubMed ID: 25699398
[TBL] [Abstract][Full Text] [Related]
56. Splenectomy does not correlate with length of survival in patients undergoing curative total gastrectomy for gastric carcinoma. Univariate and multivariate analyses.
Maehara Y; Moriguchi S; Yoshida M; Takahashi I; Korenaga D; Sugimachi K
Cancer; 1991 Jun; 67(12):3006-9. PubMed ID: 2044047
[TBL] [Abstract][Full Text] [Related]
57. Prognostic factors of T4 gastric cancer patients undergoing potentially curative resection.
Fukuda N; Sugiyama Y; Wada J
World J Gastroenterol; 2011 Mar; 17(9):1180-4. PubMed ID: 21448423
[TBL] [Abstract][Full Text] [Related]
58. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
59. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
60. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
